Financial Performance - The company's operating revenue for Q1 2025 reached ¥911,071,132.46, representing a 42.42% increase compared to ¥639,711,881.28 in the same period last year[4] - Net profit attributable to shareholders was ¥90,611,325.29, a 5.67% increase from ¥85,748,400.75 year-on-year[4] - Total operating revenue for Q1 2025 reached ¥911,071,132.46, a 42.4% increase from ¥639,711,881.28 in Q1 2024[21] - Net profit for Q1 2025 was ¥90,611,325.29, representing a 5.0% increase compared to ¥85,748,400.75 in Q1 2024[22] - Earnings per share for Q1 2025 was ¥0.59, compared to ¥0.55 in Q1 2024[22] Cash Flow - The net cash flow from operating activities improved significantly to ¥40,390,306.75, compared to a negative cash flow of ¥94,242,746.79 in the previous year, marking a 142.86% change[4] - Cash flow from operating activities for Q1 2025 was ¥40,390,306.75, a significant improvement from a negative cash flow of ¥94,242,746.79 in Q1 2024[24] - The company reported a total cash outflow from operating activities of ¥823,737,609.95 in Q1 2025, compared to ¥597,338,449.33 in Q1 2024[24] - The net cash flow from investing activities was -196,359,818.84, compared to -102,673,180.86 in the previous period, indicating a significant increase in cash outflow for investments[25] - The net cash flow from financing activities was 24,051,598.14, a recovery from a negative cash flow of -88,084,003.45 in the previous period[25] Assets and Liabilities - Total assets at the end of the reporting period were ¥5,173,400,418.40, up 6.63% from ¥4,851,759,098.61 at the end of the previous year[5] - Total liabilities as of the end of the reporting period were ¥1,780,381,038.94, up from ¥1,550,622,539.98 in the previous period[18] - The total liabilities decreased from ¥1,373,000,000 to ¥1,200,000,000, indicating a reduction of approximately 12.6%[16] - The total equity attributable to shareholders was ¥3,393,019,379.46, an increase from ¥3,301,136,558.63 in the previous period[18] Shareholder Information - The total number of common shareholders at the end of the reporting period is 17,893[10] - The top three shareholders hold a combined total of 96,984,141 shares, representing 62.78% of the total shares[10] - The company has no pledged, marked, or frozen shares among the top shareholders[10] Research and Development - The company reported a 49.05% increase in R&D expenses, indicating a focus on enhancing product development[9] Acquisitions and Market Expansion - The company completed the acquisition of Hubei Sibao Hygiene Products Co., Ltd., which is now a wholly-owned subsidiary[14] - The company plans to continue expanding its market presence, particularly through the integration of Hubei Sibao into its operations[9] Inventory and Receivables - Accounts receivable rose by 148.90%, primarily due to increased customer receivables and the consolidation of Hubei Sibao[8] - Inventory rose from ¥320,919,462.61 to ¥393,824,431.15, marking an increase of approximately 22.6%[16] - Accounts receivable increased significantly from ¥136,843,080.41 to ¥340,597,759.20, reflecting a growth of about 148.5%[16] Expenses - The company experienced a 182.96% increase in selling expenses, attributed to the consolidation of Hubei Sibao and increased sales activities[9] - Total operating costs for Q1 2025 were ¥800,306,829.41, up 48.5% from ¥539,179,011.57 in Q1 2024[21] Cash Management - The company's cash and cash equivalents decreased from ¥1,382,527,655.60 to ¥1,250,598,175.32, a decline of approximately 9.5%[16] - The total cash and cash equivalents at the end of the period decreased to 1,250,598,175.32 from 2,007,274,917.96, showing a decline of approximately 37.5%[25] - The cash flow from operating activities was not detailed, but the overall cash and cash equivalents net decrease was -131,929,480.28, compared to -284,353,110.32 in the previous period, suggesting improved cash management[25] Debt Management - The company’s cash outflow for repaying debts was 199,000,000.00, slightly higher than the previous period's 190,000,000.00, indicating ongoing debt management efforts[25]
豪悦护理(605009) - 2025 Q1 - 季度财报